SCHEMBL7830

SCHEMBL7830

[C]#CCCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38767 0.90
SCHEMBL3887313 0.87
SCHEMBL38737 0.87 TSHR (0.50)
SCHEMBL1610232 0.87 TSHR (0.50)
SCHEMBL1612633 0.87 TSHR (0.50)
SCHEMBL1611665 0.87 TSHR (0.50)
SCHEMBL1613181 0.87 TSHR (0.50)
SCHEMBL131107 0.87 TSHR (0.50)
SCHEMBL22721290 0.87 TSHR (0.50)
SCHEMBL1610253 0.87 TSHR (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 20507 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4387629-A1 6-SUBSTITUTED- AND 6,7-DISUBSTITUTED-7-DEAZAPURINE RIBONUCLEOSIDE ANALOGUES Katholieke Universiteit Leuven KU Leuven Research & Development (BE) 2024-06-26 EP claimed
US-20240199542-A1 SUBSTITUTED PYRROLIDIN-2-ONES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES BAYER AKTIENGESELLSCHAFT (DE) 2024-06-20 US claimed
US-20240190875-A1 SPIROINDOLINE DERIVATIVE, AND PREPARATION METHOD AND MEDICAL USE THEREOF CHANGCHUN GENESCIENCE PHARMACEUTICAL CO., LTD. (CN) 2024-06-13 US claimed
WO-2024114635-A1 DIHYDROPHTHALAZINE-CONTAINING COMPOUND 正大天晴药业集团股份有限公司 2024-06-06 WO claimed
US-20240131040-A1 COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS Natural Extraction Systems, LLC (US) 2024-04-25 US claimed
EP-4353082-A1 HERBICIDAL COMPOSITIONS Bayer Aktiengesellschaft (DE) 2024-04-17 EP claimed
CN-117843611-A Preparation and application of triazole antitumor inhibitor 中国医学科学院药物研究所 2024-04-09 CN claimed
EP-4313943-A1 SUBSTITUTED PYRROLIDIN-2-ONES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES Bayer Aktiengesellschaft (DE) 2024-02-07 EP claimed
CN-114391013-B IRAK inhibitor and preparation method and application thereof 上海美悦生物科技发展有限公司 2024-01-26 CN claimed
US-20240025862-A1 SUBSTITUTED N-PHENYLURACILS AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES BAYER AKTIENGESELLSCHAFT (DE) 2024-01-25 US claimed
EP-0695741-A1 7-THIAPROSTAGLANDINS AND PROCESS FOR PRODUCING THE SAME TEIJIN LIMITED (JP) 1996-02-07 EP claimed
EP-0637965-A4 ENHANCED TRIPLE-HELIX AND DOUBLE-HELIX FORMATION WITH OLIGOMERS CONTAINING MODIFIED PYRIMIDINES. GILEAD SCIENCES INC (US) 1996-01-24 EP claimed
WO-1995029904-A1 SUBSTITUTED THIAZOLE SULFONAMIDES AS ANTIGLAUCOMA AGENTS ALLERGAN (US) 1995-11-09 WO claimed
EP-0477646-B1 Substituted 5-alkoxy-1,2,4-triazol-3-(thi)ones BAYER AG (DE) 1995-03-01 EP claimed
EP-0637965-A1 ENHANCED TRIPLE-HELIX AND DOUBLE-HELIX FORMATION WITH OLIGOMERS CONTAINING MODIFIED PYRIMIDINES GILEAD SCIENCES, INC. (US) 1995-02-15 EP claimed
US-5258509-A Catalytic detherification and alkylation BANYU PHARMACEUTICAL CO., LTD. (JP) 1993-11-02 US claimed
US-5227505-A Chemical intermediates for prostaglandins NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 1993-07-13 US claimed
WO-1993010820-A1 ENHANCED TRIPLE-HELIX AND DOUBLE-HELIX FORMATION WITH OLIGOMERS CONTAINING MODIFIED PYRIMIDINES GILEAD SCIENCES, INC. (US) 1993-06-10 WO claimed
EP-0520336-A2 Aldehyde derivatives and their use as calpain inhibitors FUJIREBIO Inc. (JP) 1992-12-30 EP claimed
US-4820836-A ANTICOAGULANTS, ANTIULCER AGENTS SHIONOGI & CO., LTD. (JP) 1989-04-11 US claimed